Track topics on Twitter Track topics that are important to you
The National Institute for Health and Care Excellence (NICE) thas recommended Epclusa (sofosbuvir-velpatasvir),…
Original Article: NICE backs Gilead’s hepatitis C drug EpclusaNEXT ARTICLE
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...